<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="111071">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02067065</url>
  </required_header>
  <id_info>
    <org_study_id>ColonPropo-01</org_study_id>
    <nct_id>NCT02067065</nct_id>
  </id_info>
  <brief_title>Non-anesthesiologist Administered Propofol Sedation for Colonoscopy - a Randomized Clinical Trial</brief_title>
  <official_title>Non-anesthesiologist Administered Propofol Sedation for Colonoscopy - a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Beatriz Ângelo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Beatriz Ângelo</source>
  <oversight_info>
    <authority>Portugal: Data Protection Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Propofol is the preferred sedation for colonoscopy. There is debate on the safety of the
      administration of propofol by non-anesthesiologists, despite moderate quality evidence that
      support its' use.

      There is only one small trial of a direct comparison of propofol sedation by
      anesthesiologists versus non-anesthesiologists.

      Our aim is to compare the incidence of sedation related adverse events, the procedural
      quality indicators, times (onset, recovery, discharge) and patient satisfaction between
      non-anesthesiologist administered propofol sedation (NAAP) sedation and anesthesiologist
      propofol sedation.

      A randomized clinical trial with the incidence of sedation related minor adverse events as
      primary endpoint will be conducted. Secondary endpoints include procedure quality
      indicators, propofol dosage and patient satisfaction.

      A sample size of 330 subjects (2 arms of 165 patients) will be needed in order to obtain 90%
      power and a 5% significance level to detect a 15% difference (15 - 30%) in adverse events
      incidence, estimated from our pilot experience. The sample size was adjusted for a 2%
      cross-over rate.

      Informed and consenting patients undergoing colonoscopy examinations will be randomly
      assigned to one of two arms. One group will be sedated by an anesthesiologist according to a
      protocol of propofol mono-sedation. The other group will be sedated with propofol boluses,
      according to the European Society of Gastrointestinal Endoscopy (ESGE) NAAP guideline, with
      a 3-man team consisting of one endoscopist, one endoscopy nurse and a sedation nurse,
      trained in NAAP and exclusively dedicated to sedation and patient monitoring.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Minor adverse events</measure>
    <time_frame>During the sedation period</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Minor adverse events as defined by the International Sedation Task Force, including peripheral O2 saturation between 75-90% for less than 60 seconds, apnea, airway obstruction, sedation failure, allergic reaction without anaphylaxis, convulsion, brady/tachycardia and hypo/hypertension (&gt;25% change from baseline)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Propofol dosage</measure>
    <time_frame>During the colonoscopy - an estimated mean time of 20 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total propofol dosage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>Before discharge - estimated mean recovery time of 1 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>A 10 point visual scale on pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>colonoscopy quality indicators</measure>
    <time_frame>During the procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Colonoscopy quality indicators: time to cecum, withdrawal time, adenoma detection rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction 2</measure>
    <time_frame>Before discharge - estimated mean recovery time of 1 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>A 5 point likert scale on patient satisfaction with the sedation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Digestive System Diseases</condition>
  <condition>Colonoscopy Sedation</condition>
  <arm_group>
    <arm_group_label>Non-anesthesiologist propofol sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bolus propofol sedation by non-anesthesiologist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anesthesiologist administered propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol sedation administered by an anesthesiologist</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Non-anesthesiologist propofol sedation</intervention_name>
    <description>Bolus propofol sedation administered according to non-anesthesiologist propofol sedation guidelines of the European Society of Gastrointestinal Endoscopy</description>
    <arm_group_label>Non-anesthesiologist propofol sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol sedation administered by an anesthesiologist</intervention_name>
    <description>Propofol sedation by an anesthesiologist</description>
    <arm_group_label>Anesthesiologist administered propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colonoscopy</intervention_name>
    <description>Elective total colonoscopy with or without biopsies, polypectomies or mucosal resection, as clinically indicated</description>
    <arm_group_label>Non-anesthesiologist propofol sedation</arm_group_label>
    <arm_group_label>Anesthesiologist administered propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Referred for elective colonoscopy as outpatients

          -  Must be able to provide the informed consent

        Exclusion Criteria:

          -  American Society of Anaesthesiologists (ASA) class &gt;2

          -  Pregnant women

          -  Difficult airway predictors (more than 2 ou Mallampati &gt;3)

          -  Allergy to propofol or its' components

          -  IV drugs abuse
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre O Ferreira, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Beatriz Ângelo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexandre O Ferreira, MD</last_name>
    <phone>+351 965389966</phone>
    <email>alex.gastrohep@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Beatriz Ângelo</name>
      <address>
        <city>Loures</city>
        <zip>2674-514</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marilia Cravo, MD, PhD</last_name>
      <phone>+351 919439192</phone>
      <email>marilia.cravo@hbeatrizangelo.pt</email>
    </contact>
    <investigator>
      <last_name>Alexandre O Ferreira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <reference>
    <citation>Dumonceau JM, Riphaus A, Aparicio JR, Beilenhoff U, Knape JT, Ortmann M, Paspatis G, Ponsioen CY, Racz I, Schreiber F, Vilmann P, Wehrmann T, Wientjes C, Walder B; NAAP Task Force Members. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy. 2010 Nov;42(11):960-74. doi: 10.1055/s-0030-1255728. Epub 2010 Nov 11.</citation>
    <PMID>21072716</PMID>
  </reference>
  <reference>
    <citation>Dumonceau JM, Riphaus A, Beilenhoff U, Vilmann P, Hornslet P, Aparicio JR, Dinis-Ribeiro M, Giostra E, Ortmann M, Knape JT, Ladas S, Paspatis G, Ponsioen CY, Racz I, Wehrmann T, Walder B. European curriculum for sedation training in gastrointestinal endoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA). Endoscopy. 2013 Jun;45(6):496-504. doi: 10.1055/s-0033-1344142. Epub 2013 May 23.</citation>
    <PMID>23702777</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 8, 2014</lastchanged_date>
  <firstreceived_date>February 16, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Beatriz Ângelo</investigator_affiliation>
    <investigator_full_name>Alexandre Ferreira</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Sedation</keyword>
  <keyword>Propofol</keyword>
  <keyword>Non-anesthesiologist propofol administration</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Digestive System Diseases</mesh_term>
    <mesh_term>Gastrointestinal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
